Under the terms of the merger agreement, Sanofi will acquire DR-0201 through the acquisition of the Dren Bio affiliate ...
Sanofi (NASDAQ:SNY) has struck a major deal to acquire Dren Bios autoimmune disease treatment, DR-0201, reinforcing its ...
Madness: Watch DraftKings, FanDuel, Robinhood, and Grand Canyon. CoreWeave seeks shares ranging from $47 to $55 in IPO:report ...
The CDC has rescheduled a key advisory committee meeting on vaccine experts to April following a delay in February, a week ...
Hosted on MSN11d
The Nasdaq is Cratering But REGN, BIIB and CSGP Are Up Big TodayAnd while it’s wreaking havoc on most stocks, some are bucking the trend, including: While markets sink, Regeneron ...
Jones Financial Companies Lllp raised its stake in Sanofi (NASDAQ:SNY – Free Report) by 55.0% during the 4th quarter, ...
HighTower Advisors LLC increased its position in shares of Sanofi (NASDAQ:SNY – Free Report) by 3.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The ...
Below is Validea's guru fundamental report for SANOFI SA (ADR) (SNY). Of the 22 guru strategies we follow, SNY rates highest using our Acquirer's Multiple Investor model based on the published ...
(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi presented positive results ... author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew ...
Read Our Latest Research Report on Sanofi Sanofi Stock Up 2.0 % SNY opened at $58.92 on Tuesday. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.46 and a quick ratio of 1.14 ...
The U.S. Department of Agriculture (USDA) on Thursday announced a $100M investment to combat the transmission of the bird flu virus in poultry, adding to the Trump administration's previously ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results